65.49 USD
+0.64 (+0.99%)
Last: Feb 11, 2026, 12:39 PM
ChartMill assigns a Buy % Consensus number of 81% to CYTK. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 91.56. This target is 39.81% above the current price.
- CYTK was analyzed by 26 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about CYTK.
- In the previous month the buy percentage consensus was at a similar level.
- CYTK was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-03 | Truist Securities | Maintains | Buy -> Buy |
| 2026-01-21 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2026-01-21 | B. Riley Securities | Maintains | Buy -> Buy |
| 2026-01-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-22 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-12-22 | Needham | Maintains | Buy -> Buy |
| 2025-12-22 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-22 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-12-19 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-12-12 | Needham | Reiterate | Buy -> Buy |
| 2025-11-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-10 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2025-10-06 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-02 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-09-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-22 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-09-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-03 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-03 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-02 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-09-02 | Needham | Reiterate | Buy -> Buy |
| 2025-09-02 | Stifel | Maintains | Buy -> Buy |
| 2025-09-02 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-08 | Citigroup | Maintains | Buy -> Buy |
| 2025-06-09 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-29 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-05-14 | Needham | Reiterate | Buy -> Buy |
| 2025-05-08 | Barclays | Maintains | Overweight -> Overweight |
CYTOKINETICS INC / CYTK FAQ
What is the price target for CYTK stock?
26 analysts have analysed CYTK and the average price target is 91.56 USD. This implies a price increase of 39.81% is expected in the next year compared to the current price of 65.49.
Can you provide the consensus rating for CYTOKINETICS INC stock?
The consensus rating for CYTOKINETICS INC (CYTK) is 80.7692 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover CYTOKINETICS INC (CYTK) stock?
The number of analysts covering CYTOKINETICS INC (CYTK) is 26.